International Regulator Consortium Eyes Real-World Data
Lessons To Be Learned From Use Of COVID-19 Flexibilities
The five-member ACCESS Consortium has outlined how it intends to build on its work-sharing experiences by applying innovative regulatory practices to the assessment of increasingly complex medicinal products.
